son of T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: smh who wrote (417)	1/12/2000 7:53:00 AM
From: Jim Oravetz	of 673

Here is a listing of headlines, re:biotech and pharma from yesterdays WSJ DiagnoCure/ImmunoCyt -2: FDA Requested Added Data St Jude CFO: 2-Chamber Defibrillator As Early As Late '00 PlanetRx To Be CCN Managed Care's Exclusive Web Pharmacy Boston Life Anti-Cancer Protein Suppresses Animal Tumors Transkaryotic: Phase III Study Focuses On Renal Studies Ribozyme, Elan Complete Joint Venture Pact Synsorb Says Early 2002 Cd Approval Now Likely Celanese AG To Sell Global Phosphorus Unit To Mgmt Dura Pharma Chmn:Key Patented Pdts Had Strong '99 Growth Biotech Value Grp Reports 11.8% Advanced Magnetics Stake Medco, King Pharm Subject Of Complaint Against Merger Britain's Flu Misery A Welcome Tonic For Drug-Sellers Genzyme Surgical Products 4Q Revenue $30M Vs $28M Targeted Genetics Licenses Key Gene Expression Tech Ares-Serono To Pay Alkermes About $30M, Plus Royalty Genzyme General Puts 4Q Revenue At $173M Vs $155M Cell Pathways:FDA To Review Aptosyn NDA W/Out Panel Input Roche 1999 Sales Seen Up Around 9.5% - Analysts Gilead Pharm Begins 2nd Phase III Hepatitis B Drug Study Hemosol Inc. To Sell 4.8M Shares At C$8.35 Each Vion Pharma, AstraZeneca In Anticancer Drug Venture Eli Lilly, Ribozyme File IND For Antihepatitis Ribozyme Aurora Biosciences Tests Fast Drug-Screening System Trega Biosciences, Boehringer Ingelhneim In Venture Ariad Pharma Up In Premarket; Co. Has 2 New Patents German Business Briefs: Celanese Sells Thermphos To Mgmt Corixa Gets FDA OK To Begin Phase II PVAC Trials Avant Immunotherapeutics Names Avery Catlin Fincl Chief Progenics Reports Step In HIV Vaccine Development Bespak Gets Two New Deals, But Trading Remains Uncertain Alexion Files IND For Psoriasis Treatment Phas Ib Novoste Inc. Sees 2Q PMA For Restenosis Treatment Bio-Tech Genl, Genentech Patent Trial Begins Lots and lots of activity. FWIW Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next